All correspondence related to the Board, including correspondence to and from Board members, shall be subject to the Freedom of Information Act.
One non-voting clinician recommended by an association of Medicaid managed care health plans shall serve a term of 3 years on the Board without compensation.
Organizations interested in nominating non-voting clinicians to advise the Board may submit requests to participate to the Illinois Department.
A licensed physician recommended by the Rare Disease Commission who is a rare disease specialist and possesses scientific knowledge and medical training with respect to rare diseases and is familiar with drug and biological products and treatment shall be notified in advance to attend an Illinois Drug and Therapeutics Advisory Board meeting when a drug or biological product is scheduled to be reviewed in order to advise and make recommendations on drugs or biological products.
305 ILCS 5/5-30.14